The COVID-19 pandemic has been called a “stress test” for open science — one that, by most accounts, it passed. The sharing of new scientific knowledge and data about the SARS-CoV-2 virus and its impacts has been fast and furious. But not all experts are convinced that open will become the new norm for science in Canada. At least, not yet.
Person: Dr Aled Edwards
Ontario budget cuts more than $300 million in research and innovation funding
Drug discovery requires a new paradigm
Editor’s Note: As drug development costs rapidly spiral upwards, the number of new drug approvals continues to drop. The pharmaceutical industry is closing many of its North American R&D clusters and moving to lower-cost jurisdictions.